Emerging evidence from transcriptional profiling points to the downregulation of ELF5 as a pivotal driver of the aging phenotype in luminal epithelial progenitor cells, with potential implications for increased breast cancer susceptibility. This evidence concerns the gene ELF5 and breast cancer.